急性肾损伤
医学
肾
线粒体
肽
癌症研究
药理学
细胞凋亡
缺氧(环境)
肾干细胞
程序性细胞死亡
肾功能
化学
细胞
生物信息学
细胞生物学
功能(生物学)
细胞色素c
缺氧诱导因子
半胱氨酸蛋白酶
半胱氨酸蛋白酶3
肾脏疾病
治疗方法
HEK 293细胞
线粒体内膜
作者
Xiaoyao Zhang,Shihui Lin,Tianyu Wu,Zhixin Zhang,Hong Zhou,Xue Hong,Youhua Liu
摘要
Acute kidney injury (AKI) is a clinical syndrome associated with severe morbidity and high mortality, for which there are no currently effective therapies. Aging, a state associated with Klotho protein decline, is an independent risk factor for AKI development and progression. Here, we report that Klotho-derived peptide 1 (KP1), a small peptide that recapitulates the renoprotective potential of Klotho, effectively protects against AKI in mouse models induced by either cisplatin or ischemia-reperfusion injury. KP1 treatment improved kidney function, ameliorated structural damage, inhibited tubular cell apoptosis, and preserved mitochondrial integrity in both models. Mechanistically, KP1 entered kidney proximal tubular epithelial cells via endocytosis, directly targeted the mitochondrial protein ATPase family AAA domain-containing protein 3A (ATAD3A), and prevented its degradation, and preserved its function. By interacting with the hypoxia inducible gene 1 (HIG1) domain family member 2A (HIGD2A) and maintaining its expression and function within the mitochondria, ATAD3A prevented cytochrome c release and inhibited caspase activation following injury, thereby alleviating renal tubular cell apoptosis. Collectively, these studies demonstrate that KP1 is a promising therapeutic agent for AKI by directly targeting and preserving mitochondrial integrity. Our findings also lay the groundwork for developing novel therapeutic strategies to treat diseases associated with mitochondrial dysfunction.
科研通智能强力驱动
Strongly Powered by AbleSci AI